Showing 63,961 - 63,980 results of 100,619 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( 5 ((point decrease) OR (mean decrease)) ))', query time: 1.77s Refine Results
  1. 63961

    Inpatient postpartum contraception provision among individuals with opioid use disorder in Maine, 2016–2023 by Catherine Gelsinger (15391022)

    Published 2025
    “…<p>To compare trends in inpatient postpartum (IPP) long-acting reversible contraception (LARC) and permanent contraception provision among women with and without opioid use disorder (OUD) in Maine, which has recently seen a decrease in prevalence of maternal OUD.</p> <p>We used diagnosis codes recorded in hospital discharge data to identify deliveries with and without OUD in Maine during 2016–2023. …”
  2. 63962

    Natural Killer Cell Function, an Important Target for Infection and Tumor Protection, Is Impaired in Type 2 Diabetes by Jeannig Berrou (407033)

    Published 2013
    “…Compared with healthy blood donors, diabetic patients showed a profound decrease in both NKG2D-positive NK cells (44% <i>vs.…”
  3. 63963

    Data_Sheet_8_Trends in the global burden of vision loss among the older adults from 1990 to 2019.DOCX by Jiayang Yin (9273813)

    Published 2024
    “…YLDs associated with vision loss saw a significant decrease, moving from 1713.5 (95% UI: 1216.2–2339.7) to 1579.1 (95% UI: 1108.3–2168.9, AAPC: −0.12). …”
  4. 63964

    Data_Sheet_1_Trends in the global burden of vision loss among the older adults from 1990 to 2019.DOCX by Jiayang Yin (9273813)

    Published 2024
    “…YLDs associated with vision loss saw a significant decrease, moving from 1713.5 (95% UI: 1216.2–2339.7) to 1579.1 (95% UI: 1108.3–2168.9, AAPC: −0.12). …”
  5. 63965

    Data_Sheet_6_Trends in the global burden of vision loss among the older adults from 1990 to 2019.DOCX by Jiayang Yin (9273813)

    Published 2024
    “…YLDs associated with vision loss saw a significant decrease, moving from 1713.5 (95% UI: 1216.2–2339.7) to 1579.1 (95% UI: 1108.3–2168.9, AAPC: −0.12). …”
  6. 63966

    Effect of Ex-4 on high glucose-induced ROS production. by Ji-Won Kim (174475)

    Published 2016
    “…Quantified data shows that 8-OHdG positive cells were significantly decreased in Ex-4 group compared to other groups. The values represent the mean ± S.E of 5 experiments and are expressed as percent of LG value. (*, p<0.05 versus low glucose. **, p<0.001 versus low glucose.) …”
  7. 63967

    Time to virus extinction. by Jose Gabriel Nino Barreat (17996467)

    Published 2024
    “…<p>The time to virus extinction also decreases as a function of the cell number and condition in the simulations. …”
  8. 63968

    Indirubin increased the levels of CD4<sup>+</sup>CD25<sup>+</sup>Treg cells in the thymi of ITP mice. by Aijun Zhang (140095)

    Published 2015
    “…<p><b>A</b>, The total cell number of thymocytes were decreased in ITP and indirubin-treated ITP mice. …”
  9. 63969

    TLR2Ab suppressed the expression of endogenous TLR2 agonists and interaction of TLR2 with HMGB1. by Yonggang Ma (316106)

    Published 2013
    “…(B) TLR2Ab and TLR4Ab suppressed its downstream signaling pathway. Data are shown as mean ± SEM (n = 5/group). (C) TLR2Ab inhibited the interaction of TLR2 with HMGB1 as indicated by co-immunoprecipitation and western blot. …”
  10. 63970

    8oxoG and AP lesions disrupt TRF2 recognition of telomeric DNA by Patricia L. Opresko (7493)

    Published 2011
    “…All rights reserved</p> Boxes indicate the GGG runs of the tandem telomeric repeats, and (X) marks the position of 8oxoG () or abasic () lesion(s) within the G runs (see ). Substrates (2.5 nM) were incubated alone (−) or together with decreasing concentrations of TRF2 (200, 100, 50 or 25 nM) for 20 min at 4°C in TRF2 binding buffer. …”
  11. 63971

    Impairment of pronephros development upon indomethacin treatment. by Jens H. Westhoff (492734)

    Published 2013
    “…<p>(A) Overview of pronephric alterations in zebrafish larvae (50 hpf) following indomethacin administration for 24 hours. …”
  12. 63972

    Direct pathways of E2 on MCF-7 mammosphere proliferation. by Ji-Won Jung (194917)

    Published 2011
    “…(B) Number of mammospheres was decreased by co-treatment with ICI 182,780. Data were presented as the number of mammospheres per 1,000 seeded cells at 5d (mean ± S.D., n = 3). **, <i>P</i><0.01; ***, <i>P</i><0.001. …”
  13. 63973

    Image1_Comparison of perventricular and percutaneous ultrasound-guided device closure of perimembranous ventricular septal defects.tif by Liu Liu Huang (17339485)

    Published 2023
    “…</p>Results<p>Patients of the PCP and PVP groups had a median age of 4.9 years (IQR, 3.1–14.0) and 5.3 years (IQR, 3.4–13.1) respectively. …”
  14. 63974

    Multi-way sensitivity analysis on regional access to care and linkage to care with POC-CD4 compared to LAB-CD4. by Emily P. Hyle (512613)

    Published 2014
    “…<p>Projected decrease in 5-y mortality and ICERs with use of POC-CD4 compared to LAB-CD4 in four settings that represent a range of access to care (decreasing access to care from left to right) and with different probabilities of linkage with POC-CD4 (increasing up the vertical axis). …”
  15. 63975

    Effects of HDAC8 inhibition on MPNST cell cycle and apoptosis. by Gonzalo Lopez (22820)

    Published 2015
    “…<p><b>A.</b> PI staining/FACS analyses showing the effect of HDACis (PCI2 0.5μM/48h, PCI3/4 5μM/48h) on human and murine-derived MPNST cell cycle progression. …”
  16. 63976

    Table2_Comparison of perventricular and percutaneous ultrasound-guided device closure of perimembranous ventricular septal defects.docx by Liu Liu Huang (17339485)

    Published 2023
    “…</p>Results<p>Patients of the PCP and PVP groups had a median age of 4.9 years (IQR, 3.1–14.0) and 5.3 years (IQR, 3.4–13.1) respectively. …”
  17. 63977

    Table1_Comparison of perventricular and percutaneous ultrasound-guided device closure of perimembranous ventricular septal defects.docx by Liu Liu Huang (17339485)

    Published 2023
    “…</p>Results<p>Patients of the PCP and PVP groups had a median age of 4.9 years (IQR, 3.1–14.0) and 5.3 years (IQR, 3.4–13.1) respectively. …”
  18. 63978

    Table_7_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

    Published 2024
    “…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”
  19. 63979

    Table_8_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

    Published 2024
    “…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”
  20. 63980

    Table_3_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

    Published 2024
    “…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”